Shiwen Deng

460 total citations · 1 hit paper
18 papers, 279 citations indexed

About

Shiwen Deng is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Shiwen Deng has authored 18 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Biomedical Engineering. Recurrent topics in Shiwen Deng's work include Mesenchymal stem cell research (5 papers), Andrographolide Research and Applications (2 papers) and Pluripotent Stem Cells Research (2 papers). Shiwen Deng is often cited by papers focused on Mesenchymal stem cell research (5 papers), Andrographolide Research and Applications (2 papers) and Pluripotent Stem Cells Research (2 papers). Shiwen Deng collaborates with scholars based in China, Finland and United States. Shiwen Deng's co-authors include Caifeng Li, Junxian Cao, Zhao Cui, Jiang Du, Peng Chen, Tong Lei, Hongjun Yang, Xiaoshuang Zhang, Hongwu Du and Peng Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and International Journal of Molecular Sciences.

In The Last Decade

Shiwen Deng

18 papers receiving 272 citations

Hit Papers

Organ-on-a-chip meets art... 2023 2026 2024 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiwen Deng China 10 120 101 29 29 24 18 279
Kateřina Štefková Czechia 6 163 1.4× 47 0.5× 28 1.0× 17 0.6× 26 1.1× 7 302
Peggy Arthur United States 11 184 1.5× 79 0.8× 23 0.8× 33 1.1× 64 2.7× 16 342
Iris Bischoff Germany 11 220 1.8× 95 0.9× 27 0.9× 33 1.1× 39 1.6× 17 458
Feida Li China 11 169 1.4× 70 0.7× 10 0.3× 20 0.7× 34 1.4× 18 346
Y Yu China 10 130 1.1× 39 0.4× 37 1.3× 34 1.2× 41 1.7× 22 331
Dimitrios Giakoumettis Greece 10 81 0.7× 37 0.4× 69 2.4× 30 1.0× 34 1.4× 30 296
Mitsue Hibino Japan 8 254 2.1× 77 0.8× 18 0.6× 10 0.3× 15 0.6× 12 395
Sai Zhang China 8 137 1.1× 39 0.4× 19 0.7× 15 0.5× 46 1.9× 22 280
Vahid Hosseini Iran 12 172 1.4× 64 0.6× 17 0.6× 13 0.4× 51 2.1× 23 344
En‐Chi Liao Taiwan 12 159 1.3× 115 1.1× 7 0.2× 18 0.6× 37 1.5× 24 383

Countries citing papers authored by Shiwen Deng

Since Specialization
Citations

This map shows the geographic impact of Shiwen Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiwen Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiwen Deng more than expected).

Fields of papers citing papers by Shiwen Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiwen Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiwen Deng. The network helps show where Shiwen Deng may publish in the future.

Co-authorship network of co-authors of Shiwen Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Shiwen Deng. A scholar is included among the top collaborators of Shiwen Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiwen Deng. Shiwen Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Yanan, et al.. (2025). Functional material probes and advanced technologies in organ-on-a-chip characterization. Theranostics. 16(5). 2488–2516. 1 indexed citations
2.
Li, Jiameng, Caifeng Li, Shiwen Deng, et al.. (2025). Identifying the target, mechanism, and agonist of α-ketoglutaric acid in delaying mesenchymal stem cell senescence. Cell Reports. 44(7). 115917–115917. 2 indexed citations
3.
Li, Caifeng, et al.. (2024). Scutellarin activates IDH1 to exert antitumor effects in hepatocellular carcinoma progression. Cell Death and Disease. 15(4). 267–267. 12 indexed citations
4.
Lei, Tong, Caifeng Li, Yang Liu, et al.. (2024). Microfluidics-enabled mesenchymal stem cell derived Neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson’s Disease. Journal of Nanobiotechnology. 22(1). 370–370. 16 indexed citations
5.
Tong, Lei, Xiaoshuang Zhang, Shiwen Deng, et al.. (2024). Advances in human cellular mechanistic understanding and drug discovery of brain organoids for neurodegenerative diseases. Ageing Research Reviews. 102. 102517–102517. 9 indexed citations
6.
Cao, Junxian, Caifeng Li, Shiwen Deng, et al.. (2024). Spatial Transcriptomics: A Powerful Tool in Disease Understanding and Drug Discovery. Theranostics. 14(7). 2946–2968. 27 indexed citations
7.
Deng, Shiwen, Caifeng Li, Junqi Chen, et al.. (2023). Effects of triclosan exposure on stem cells from human exfoliated deciduous teeth (SHED) fate. The Science of The Total Environment. 905. 167053–167053. 5 indexed citations
8.
Deng, Shiwen, Caifeng Li, Junxian Cao, et al.. (2023). Organ-on-a-chip meets artificial intelligence in drug evaluation. Theranostics. 13(13). 4526–4558. 103 indexed citations breakdown →
9.
Li, Caifeng, et al.. (2023). Programmed Cell Death Protein 2-like Promotes Inflammation and Oxidative Stress in Vascular Endothelial Cells. ACS Pharmacology & Translational Science. 6(10). 1453–1470. 1 indexed citations
11.
Lei, Tong, et al.. (2022). Hydrogel supplemented with human platelet lysate enhances multi-lineage differentiation of mesenchymal stem cells. Journal of Nanobiotechnology. 20(1). 176–176. 11 indexed citations
12.
Cui, Zhao, et al.. (2022). Chip-DSF: A rapid screening strategy for drug protein targets. Pharmacological Research. 182. 106346–106346. 7 indexed citations
13.
Lei, Tong, et al.. (2022). Chitosan Hydrogel Supplemented with Metformin Promotes Neuron–like Cell Differentiation of Gingival Mesenchymal Stem Cells. International Journal of Molecular Sciences. 23(6). 3276–3276. 21 indexed citations
14.
Li, Caifeng, et al.. (2022). The potential of plant extracts in cell therapy. Stem Cell Research & Therapy. 13(1). 472–472. 12 indexed citations
15.
Cui, Zhao, et al.. (2022). Establishment of a protein thermal shift chip (PTSC) for COVID-19 and exploration of the future of protein chips in pharmacology. SHILAP Revista de lepidopterología. 1(3). 2 indexed citations
16.
Lei, Tong, Xiaoshuang Zhang, Donghui Wang, et al.. (2022). Transfer of Tumor-Bearing Mice Intestinal Flora Can Ameliorate Cognition in Alzheimer’s Disease Mice. Journal of Alzheimer s Disease. 86(3). 1287–1300. 19 indexed citations
17.
Wang, Lei, Caifeng Li, Chunyuan Liu, et al.. (2022). Identification of PDCD2 as a Candidate Target of Andrographolide That Arrests the Tumor Cell Cycle by Human Proteome-Scale Screening. ACS Pharmacology & Translational Science. 5(7). 479–490. 3 indexed citations
18.
Lei, Tong, Shiwen Deng, Peng Chen, et al.. (2021). Metformin enhances the osteogenesis and angiogenesis of human umbilical cord mesenchymal stem cells for tissue regeneration engineering. The International Journal of Biochemistry & Cell Biology. 141. 106086–106086. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026